Pregnant Women's medication habits under the microscope
NCT ID NCT07273214
First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study will survey 420 pregnant women in their third trimester in Assiut, Egypt, to understand their knowledge, attitudes, and practices around self-medication. Participants will answer a questionnaire about what medications they take, why, and where they get information. The goal is to identify awareness gaps and promote safer medication use during pregnancy.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- What this could lead to
- If successful, this study could highlight gaps in knowledge and guide educational programs to reduce risky self-medication during pregnancy.
- What could go wrong
- This is an observational survey, not a treatment trial. It cannot prove cause and effect, and results may not apply to other regions or populations.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Participants
-
About 420 people
The number the study aims to enrol. It can still change while the study runs.
- Expected to start
-
Dec 2026
An estimate. Start dates often move.
- Expected to finish
-
Feb 2027
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
Who is studied
The study population includes third-trimester pregnant women attending the antenatal care outpatient clinics at Assiut University Hospital and selected primary health care centers in Assiut Governorate, Egypt, during the study period.
- Ages
-
18 to 45 years
- Sex
-
Female participants only
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Pregnant women in the third trimester (≥28 weeks of gestation) * Attending antenatal care at Assiut University Hospital or selected primary health centers during the study period * Willing to participate and able to provide informed consent Exclusion Criteria: * Pregnant women with known psychiatric disorders or cognitive impairment that may affect questionnaire reliability. * Women with severe obstetric complications requiring emergency management. * Women unwilling to participate or unable to complete the interview.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Third trimeser are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The official record
ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.